Zyagnum AG

We are convinced that early detection of diseases is the prerequisite for better treatment options and thus optimal chances of recovery. That is why we are driven by the vision of making chronic health imbalances diagnosable even before the disease can manifest itself. This is the prerequisite for turning the early detection of life-changing diseases such as cancer, Alzheimers or diabetes into true prevention. Our aim is to make our diagnostics as simple, cost-effective, and burden-free as possible so that as many people as possible can benefit from them. Imprint: https://www.zyagnum.com/en/imprint/ Privacy Policy: https://bit.ly/3d1YHzO

Biotechnology,diagnostics,cancer screening,new generation flow cytometry,universal cancer test,edim detect,edim technology,and illuminizer

Zyagnum ag operates in the Biotechnology industry.

Zyagnum ag's revenue is 11m - 100m

Zyagnum ag has 11 - 50 employees.